Navigation Links
KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis
Date:6/23/2009

The Keystone Peer Review Organization, Inc. (KePRO), a leading quality improvement and care management organization, is pleased to announce the donation of $12,260 to the Cystic Fibrosis Foundation.

Harrisburg, PA (Vocus) June 23, 2009 -- The Keystone Peer Review Organization, Inc. (KePRO), a leading quality improvement and care management organization, is pleased to announce the donation of $12,260 to the Cystic Fibrosis Foundation.    

KePRO employees from offices located in six different states recently took part in the CF Great Strides walk in an effort to raise money for the Cystic Fibrosis Foundation. The combined efforts of the employees, both those who made the walk and those who collected funds from their family, friends and neighbors, proudly raised $7260.25 for the cause. In addition to its employees' efforts, KePRO generously donated another $5,000 to advance the mission of the Cystic Fibrosis Foundation, bringing the total KePRO donation to $12,260.

"I am very proud of KePRO employees, their families and friends who all contributed so generously to help fight this disease," said Joe Dougher, Chief Executive Officer of KePRO. "Everyone put a considerable amount of time and effort into making this fund-raising event a success and they more than surpassed my expectations. The KePRO family is truly a caring team."

The Cystic Fibrosis Foundation is a nonprofit donor-supported organization that strives to assure the development of the means to cure and control cystic fibrosis and to improve the quality of life for those with the disease. The Foundation is the leading organization in the United States devoted to cystic fibrosis. It funds and accredits more than 115 CF care centers, 95 adult care programs and 50 affiliate programs, and has 80 chapters and branch offices nationwide.

Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). In the 1950s, few children with cystic fibrosis lived to attend elementary school. Today, advances in research and medical treatments have further enhanced and extended life for children and adults with CF. Many people with the disease can now expect to live into their 30s, 40s and beyond.

About KePRO
KePRO, a leading quality improvement and care management organization, offers innovative and outcomes-focused solutions to reduce the utilization of health care resources and optimize quality of care for public and commercial clients. KePRO's comprehensive, member centric care management solutions go far beyond traditional utilization and case management by coordinating the care provided to members with acute, chronic and complex conditions across the continuum, and identifying members who are at the highest risk for future services, but have not yet had an acute event. Tailored programs maximize members' quality of life, and realize greater cost savings for members and clients.

Headquartered in Pennsylvania, KePRO also has offices in Florida, Maryland, Ohio, Tennessee, and Virginia. KePRO is URAC health utilization management and case management accredited. For more information, visit www.kepro.org.

For more information contact:
Joanne Benteler
Public Relations Director
717.265.7004
jbentele(at)kepro.org

###

Read the full story at http://www.prweb.com/releases/Care_Management/Cystic_Fibrosis/prweb2568004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. CBCA Administrators, Inc. Announces Strategic Partnership with KePRO
2. Shawn Hanley Named KePRO Director of Business Development - Public Programs
3. Stuart Chesky, DO, JD, Ohio KePRO Medical Director, Appointed to Ohio Joint Legislative Study Commission on Most Favored Nation Clauses in Health Care Contracts
4. KePROs Chief Medical Officer to Present and Participate in Physician Roundtable at McKesson Health Solutions Conference
5. Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director
6. KePROs Chief Medical Officer to Deliver Clinical Keynote Address
7. KePRO Appoints Two New IT Vice Presidents
8. KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director
9. Sharon McCudden Named KePRO Director of Business Process Improvement & Compliance
10. 41 Keystone Mercy Health Plan Members to Receive Scholarships from the Plan's Employees
11. Largest U.S. Health Insurer Rewarded Employees That Cancelled Coverage of Sick Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that ... clinical and commercial support services market) has entered into an agreement on September ... , The PGSD is the first private Dental School to launch an ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
(Date:9/20/2017)... ... ... Health & Safety Institute (HSI) is offering discounted pricing on its Summit ... now until November 30, 2017 to assist with the clean-up efforts from hurricanes Harvey ... and government agencies – whether or not they will be directly involved in the ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED Ezekiel's Plan for Freedom ... Freedom from ADDICTION” is the creation of published author, Bill Miller. Bill ... homeless services, including more than a decade of addiction to prescription drugs. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: